Jeanne Y. Jew's most recent trade in Crescent Biopharma Inc. was a trade of 28,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 9, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Crescent Biopharma Inc | Jeanne Y. Jew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) |